Investors often unknowingly back ventures that lack scientific governance. Clinicians operate without ECS education. Operators are left second-guessing product safety, patient communication, and regulatory language. These gaps aren’t just inefficient—they're dangerous, costly, and often exist below the surface until it’s too late.